BR0317339A - Derivados de 1-n-fenilamino-1h-imidazol e composições farmacêuticas contendo os mesmos - Google Patents
Derivados de 1-n-fenilamino-1h-imidazol e composições farmacêuticas contendo os mesmosInfo
- Publication number
- BR0317339A BR0317339A BR0317339-9A BR0317339A BR0317339A BR 0317339 A BR0317339 A BR 0317339A BR 0317339 A BR0317339 A BR 0317339A BR 0317339 A BR0317339 A BR 0317339A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- phenylamino
- imidazole derivatives
- derivatives
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 150000002460 imidazoles Chemical class 0.000 abstract 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Dentistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Plant Pathology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
"DERIVADOS DE 1-NFENILAMINO-1H-IMIDAZOL E COMPOSIçõES FARMACêUTICAS CONTENDO OS MESMOS". A presente invenção relaciona-se aos derivados de imidazol da fórmula: em que R~ 1~, R~ 2~, R~ 3~, R~ 4~, R~ 5~, R~ 6~ e n são conforme definido na especificação. A invenção também se relaciona às composições farmacêuticas que contêm estes derivados, e a seus usos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43384102P | 2002-12-16 | 2002-12-16 | |
EP02293107A EP1431292A1 (en) | 2002-12-16 | 2002-12-16 | 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors |
PCT/EP2003/015027 WO2004054983A2 (en) | 2002-12-16 | 2003-12-15 | 1-n-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0317339A true BR0317339A (pt) | 2005-11-08 |
Family
ID=42041569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0317339-9A BR0317339A (pt) | 2002-12-16 | 2003-12-15 | Derivados de 1-n-fenilamino-1h-imidazol e composições farmacêuticas contendo os mesmos |
Country Status (23)
Country | Link |
---|---|
EP (2) | EP1431291A1 (pt) |
JP (2) | JP2004196795A (pt) |
KR (1) | KR20050084299A (pt) |
CN (1) | CN100390151C (pt) |
AT (1) | ATE325102T1 (pt) |
AU (2) | AU2003268835A1 (pt) |
BR (1) | BR0317339A (pt) |
CA (1) | CA2510175C (pt) |
CY (1) | CY1106317T1 (pt) |
DE (1) | DE60305069T2 (pt) |
DK (1) | DK1572665T3 (pt) |
ES (1) | ES2264032T3 (pt) |
HK (1) | HK1083218A1 (pt) |
MA (1) | MA27502A1 (pt) |
MX (2) | MXPA03011500A (pt) |
NO (1) | NO330337B1 (pt) |
NZ (1) | NZ540643A (pt) |
PL (1) | PL377095A1 (pt) |
PT (1) | PT1572665E (pt) |
RU (1) | RU2327691C2 (pt) |
SI (1) | SI1572665T1 (pt) |
UA (1) | UA80307C2 (pt) |
ZA (1) | ZA200504570B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1890221B (zh) * | 2003-12-15 | 2014-07-16 | 沙拉麦斯实验公司 | 1-n-苯基-氨基-1h-咪唑衍生物和含有它们的医药组合物 |
US20060288955A1 (en) * | 2005-05-24 | 2006-12-28 | Wyeth | Device and method for controlling insects |
TWI368505B (en) * | 2005-05-24 | 2012-07-21 | Wyeth Corp | Versatile high load concentrate compositions for control of ecto-parasites |
WO2011057984A1 (de) * | 2009-11-11 | 2011-05-19 | Bayer Cropscience Ag | Neue diazinyl-pyrazolylverbindungen |
CN103275013A (zh) * | 2013-05-27 | 2013-09-04 | 云南大学 | 一种新型含氮杂环磺酰胺衍生物型芳香化酶抑制剂及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5232940A (en) * | 1985-12-20 | 1993-08-03 | Hatton Leslie R | Derivatives of N-phenylpyrazoles |
US6372774B1 (en) * | 1985-12-20 | 2002-04-16 | Rhone-Poulenc Agriculture Ltd. | Derivatives of N-phenylpyrazoles |
GB8531485D0 (en) * | 1985-12-20 | 1986-02-05 | May & Baker Ltd | Compositions of matter |
US4749713A (en) * | 1986-03-07 | 1988-06-07 | Ciba-Geigy Corporation | Alpha-heterocycle substituted tolunitriles |
US5071861A (en) * | 1986-03-07 | 1991-12-10 | Ciba-Geigy Corporation | Alpha-heterocycle substituted tolunitriles |
WO1993005027A1 (en) * | 1991-09-02 | 1993-03-18 | Yamanouchi Pharmaceutical Co., Ltd. | Triazolylated tertiary amine compound or salt thereof |
JP2500849B2 (ja) * | 1991-09-02 | 1996-05-29 | 山之内製薬株式会社 | トリアゾリル置換3級アミノ化合物又はその塩 |
GB2273704B (en) * | 1992-12-16 | 1997-01-22 | Orion Yhtymae Oy | Triazolyl diaryl selective aromatase inhibiting compounds |
KR20040035846A (ko) * | 2001-09-25 | 2004-04-29 | 바스프 악티엔게젤샤프트 | 살충성 및 살진드기성 3-치환된 피라졸 |
-
2003
- 2003-12-09 JP JP2003410499A patent/JP2004196795A/ja active Pending
- 2003-12-11 MX MXPA03011500A patent/MXPA03011500A/es not_active Application Discontinuation
- 2003-12-12 EP EP03257833A patent/EP1431291A1/en not_active Withdrawn
- 2003-12-15 SI SI200330353T patent/SI1572665T1/sl unknown
- 2003-12-15 MX MXPA05006530A patent/MXPA05006530A/es active IP Right Grant
- 2003-12-15 PL PL377095A patent/PL377095A1/pl not_active Application Discontinuation
- 2003-12-15 EP EP03795984A patent/EP1572665B1/en not_active Expired - Lifetime
- 2003-12-15 RU RU2005122469/04A patent/RU2327691C2/ru not_active IP Right Cessation
- 2003-12-15 PT PT03795984T patent/PT1572665E/pt unknown
- 2003-12-15 ES ES03795984T patent/ES2264032T3/es not_active Expired - Lifetime
- 2003-12-15 BR BR0317339-9A patent/BR0317339A/pt not_active Application Discontinuation
- 2003-12-15 KR KR1020057010903A patent/KR20050084299A/ko not_active Application Discontinuation
- 2003-12-15 DE DE60305069T patent/DE60305069T2/de not_active Expired - Lifetime
- 2003-12-15 CN CNB2003801051015A patent/CN100390151C/zh not_active Expired - Fee Related
- 2003-12-15 AU AU2003268835A patent/AU2003268835A1/en not_active Abandoned
- 2003-12-15 AT AT03795984T patent/ATE325102T1/de active
- 2003-12-15 CA CA2510175A patent/CA2510175C/en not_active Expired - Fee Related
- 2003-12-15 NZ NZ540643A patent/NZ540643A/en not_active IP Right Cessation
- 2003-12-15 UA UAA200505912A patent/UA80307C2/uk unknown
- 2003-12-15 DK DK03795984T patent/DK1572665T3/da active
- 2003-12-15 JP JP2004560486A patent/JP2006511546A/ja active Pending
- 2003-12-15 AU AU2003298259A patent/AU2003298259B2/en not_active Ceased
-
2005
- 2005-06-03 ZA ZA200504570A patent/ZA200504570B/en unknown
- 2005-06-08 NO NO20052780A patent/NO330337B1/no not_active IP Right Cessation
- 2005-06-22 MA MA28355A patent/MA27502A1/fr unknown
-
2006
- 2006-03-14 HK HK06103250A patent/HK1083218A1/xx not_active IP Right Cessation
- 2006-07-06 CY CY20061100935T patent/CY1106317T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2510175C (en) | 2011-07-05 |
NO330337B1 (no) | 2011-03-28 |
UA80307C2 (en) | 2007-09-10 |
CN1720235A (zh) | 2006-01-11 |
KR20050084299A (ko) | 2005-08-26 |
ATE325102T1 (de) | 2006-06-15 |
MXPA03011500A (es) | 2004-09-10 |
MXPA05006530A (es) | 2006-02-17 |
PT1572665E (pt) | 2006-09-29 |
DE60305069T2 (de) | 2006-12-07 |
AU2003298259A1 (en) | 2004-07-09 |
CY1106317T1 (el) | 2011-10-12 |
NO20052780L (no) | 2005-06-08 |
PL377095A1 (pl) | 2006-01-23 |
CA2510175A1 (en) | 2004-07-01 |
RU2327691C2 (ru) | 2008-06-27 |
ES2264032T3 (es) | 2006-12-16 |
EP1431291A1 (en) | 2004-06-23 |
DK1572665T3 (da) | 2006-08-28 |
JP2004196795A (ja) | 2004-07-15 |
RU2005122469A (ru) | 2006-02-27 |
ZA200504570B (en) | 2006-08-30 |
DE60305069D1 (de) | 2006-06-08 |
MA27502A1 (fr) | 2005-08-01 |
JP2006511546A (ja) | 2006-04-06 |
AU2003298259B2 (en) | 2009-04-02 |
EP1572665A2 (en) | 2005-09-14 |
NZ540643A (en) | 2007-11-30 |
SI1572665T1 (sl) | 2006-10-31 |
AU2003268835A1 (en) | 2004-07-01 |
HK1083218A1 (en) | 2006-06-30 |
CN100390151C (zh) | 2008-05-28 |
EP1572665B1 (en) | 2006-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0317268A (pt) | Compostos ativadores da pirazina e da piridina glucoquinase 5-substituìda, composição farmacêutica, uso e processo de preparação dos mesmos | |
BR0108678A (pt) | Novos compostos | |
BR0307960A (pt) | N-aminoacetil-pirrolidina-2-carbonitrilas e seu uso como inibidores de ddp-iv | |
BRPI0512677A2 (pt) | derivados de quinazolina | |
BR0115580A (pt) | Derivados de 3-aroilindol e a utilizaçao dos mesmos como agonistas dos receptores cb2 | |
BR0312513A (pt) | Derivados de glicosìdeo de tiofeno, processos para a produção dos mesmos, medicamentos que contêm esses compostos e uso dos mesmos | |
BR0213539A (pt) | Compostos, processo para a preparação de compostos, composições farmacêuticas que compreendem um composto método para o tratamento e/ou profilaxia de enfermidades que estão associadas com dpp iv e utilização desses compostos | |
BRPI0412689A (pt) | derivados de heteroarila e arila fundida como moduladores de metabolismo e a profilaxia e tratamento de distúrbios relacionados a ele | |
BRPI0518758A2 (pt) | compostos de acetamida como fungicidas | |
BR0314113A (pt) | Derivados de amino propanol | |
BR0009486A (pt) | Compostos que contêm uma amida, utilização desses compostos, composição farmacêutica, processo para o tratamento profilático ou terapêutico de, diabetes do tipo ii e processo para a preparação dos compostos | |
BR0115605A (pt) | Derivados de naftaleno | |
BR0316609A (pt) | Sinomenina e compostos de sinomenina, sìntese e uso | |
RS41104A (en) | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments | |
BRPI0412851A (pt) | benzamidazóis de n-metila-substituìdos | |
BR0311222A (pt) | R-enantiÈmeros de derivados de piranoindol contra hepatite c, seu método de obtenção e composição farmacêutica compreendendo os mesmos | |
BR0314635A (pt) | Derivados de piridina como moduladores de receptores de cb2 | |
BR0208053A (pt) | Sìntese de moléculas isoflavonas diméricas, composições contendo as mesmas e seus usos como agentes terapêuticos | |
UY29892A1 (es) | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones | |
BR0307461A (pt) | Derivados de quinazolinona e seu uso como agonistas de cb | |
BR0112521A (pt) | Indolquinazolinonas | |
BR0208205A (pt) | Derivados de benzimidazol moduladores de receptores de quimocinas | |
BR0314363A (pt) | Indóis 2,4-substituìdos e seu uso como moduladores de 5-ht6 | |
BR0211826A (pt) | Imidazopiridinas tricìclicas | |
BR0316108A (pt) | Derivados de fenilalquil e piridilalquil piperazina e composição farmacêutica compreendendo os mesmos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |